Skip to content

Fluoroscopic and RSA evaluation of the Triathlon total knee prosthetic design

Fluoroscopic and RSA evaluation of the Triathlon total knee prosthetic design - Triat

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON32381
Enrollment
40
Registered
2008-01-22
Start date
2009-01-09
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

artificial knee Total knee arthroplasty

Interventions

None listed

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: •Patient is diagnosed with osteoarthritis or rheumatoid arthritis and requires primary arthroplasty •Patient is capable of giving informed consent and expressing a willingness to comply with this study •Patient has no major deformities (i.e. sagittal and coronal deformities are less then 15 degrees) •The ability to perform a lunge and step-up motion without the help of bars or a cane. •No or slight pain during activity according to the Knee Society Pain Score

Exclusion criteria

Exclusion criteria: •The patient is unable or unwilling to sign the Informed Consent specific to this study •The individual has a functional impairment of any other lower extremity joint besides the operated knee •Patient has a flexion contracture of 15° and more •Patient has a varus/valgus contracture of 15° and more •Patients requiring revision arthroplasty •The patient does not understand the Dutch or English language good enough to participate. •The use of walking aids •The inability to walk more than 500 meters

Design outcomes

Secondary

MeasureTime frame
Comparison kinematics fluorosocpy and gaitanalysis Micromotion: in mm en comparison between the two designs.

Primary

MeasureTime frame
Kinematics: segment angles mobile bearing: degrees

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)